照護現場診斷市場－預測至2025-2030年

預計照護現場將從 2025 年的 367.25 億美元成長至 2030 年的 492.09 億美元，複合年成長率為 6.03%。

照護現場(POC) 市場涵蓋在傳統實驗室之外的床邊進行的檢測，由於技術進步和醫療保健需求的不斷成長，該市場正在顯著成長。 POC 檢測能夠快速評估、診斷、預後和篩檢，減少錯誤並提高效率。可攜式、手持式和可移動式設備的普及，將檢測能力從醫院擴展到家庭、緊急護理和便利診所，滿足了日益成長的便捷診斷需求。

市場促進因素

慢性病和感染疾病率上升是照護現場診斷市場的主要驅動力。中國和印度等新興國家心血管疾病和糖尿病盛行率的上升正在推動需求。例如，國際糖尿病聯盟報告稱，2021 年全球 5.37 億 20-79 歲成年人患有糖尿病，其中相當一部分國家正在經歷糖尿病。同樣，愛滋病毒和結核病等感染疾病也在刺激市場成長。聯合國愛滋病規劃署估計，2019 年有 2,060 萬人感染愛滋病毒，其中包括印度的 210 萬人，這推動了對照護現場診斷的需求，以加速治療。世界衛生組織 (WHO) 指出，印度的結核病病例負擔很高，2020 年達到 264 萬例，進一步凸顯了在資源有限的環境中快速診斷的必要性。此外，呼吸道融合細胞病毒(RSV) 每年影響全球 400 萬至 500 萬名兒童，因此需要進行 POC 檢測以有效管理此類疾病。

地理視角

預計北美地區在預測期內將見證照護現場市場顯著成長。新冠病例激增是推動快速檢測解決方案需求的主要促進因素。該地區受益於強勁的產品創新、感染疾病和慢性病的流行以及政府鼓勵早期發現和定期體檢的支持政策。美國和加拿大是關鍵市場，其驅動力包括醫療保健支出的增加、醫院和診斷實驗室數量的增加以及產業參與者之間的策略聯盟。這些因素共同推動了即時診斷設備的普及，使北美地區成為市場擴張的領導者。

由於慢性病和感染疾病的日益普及（尤其是在北美地區）、可攜式設備的技術進步以及醫療政策的扶持，照護現場診斷市場正在迅速擴張。已開發市場和新興市場對在各種環境下快速便捷診斷的需求，以及應對關鍵醫療挑戰的需求，進一步推動了市場的發展。

本報告的主要優點

• 深刻分析：獲得涵蓋主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
• 競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透。
• 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響市場的未來發展。
• 可行的建議：利用洞察力進行策略決策，在動態環境中開闢新的業務流和收益。
• 適用範圍廣：對於新興企業、科學研究機構、顧問公司、中小企業、大型企業都有利且划算。

它有什麼用途？

產業和市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

• 2022 年至 2024 年的歷史數據和 2025 年至 2030 年的預測數據
• 成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
• 競爭定位、策略和市場佔有率分析
• 各細分市場和地區（包括國家）的收益成長和預測分析

公司簡介

目錄

第1章執行摘要

第2章市場概述

• 市場概覽
• 市場定義
• 研究範圍
• 市場區隔

第3章 商業景氣

• 市場促進因素
• 市場限制
• 市場機會
• 波特五力分析
• 產業價值鏈分析
• 政策法規
• 策略建議

第4章 技術展望

第5章照護現場）

• 介紹
• 心臟代謝監測套件
• 傳染病檢查套件
• 血糖監測套件
• 凝血監測套件
• 腫瘤/癌症標記物
• 妊娠和生育能力測試
• 尿液檢查套件
• 血液檢查
• 其他

6.照護現場診斷市場（按平台）

• 介紹
• 橫向流動化驗
• 量油尺
• 微流體
• 分子診斷
• 其他

7.照護現場診斷市場（按模式）

• 介紹
• 處方箋
• 場外交易（OTC）

8.照護現場診斷市場（按最終用戶）

• 介紹
• 醫院
• 診斷中心
• 其他

第9章照護現場診斷市場（按地區）

• 介紹
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 其他
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
  • 其他

第10章競爭格局及分析

• 主要企業和策略分析
• 市場佔有率分析
• 合併、收購、協議和合作
• 競爭儀錶板

第11章 公司簡介

• Abbott Laboratories
• Becton, Dickinson and Company
• Biosynex
• Danaher Corporation
• EKF Diagnostics
• Nova Biomedical
• Quidel Corporation
• Siemens AG
• Trinity Biotech
• WerfenLife SA

第12章 附錄

• 貨幣
• 先決條件
• 基準年和預測年時間表
• 相關人員的主要利益
• 調查方法
• 簡稱

The point of care diagnostic market is expected to grow from USD 36.725 billion in 2025 to USD 49.209 billion in 2030, at a CAGR of 6.03%.

The point-of-care (POC) diagnostics market, encompassing bedside testing performed outside traditional laboratory settings, has seen significant growth driven by technological advancements and rising healthcare needs. POC testing enables rapid evaluation, diagnosis, prognosis, and screening, reducing errors and improving efficiency. The availability of portable, handheld, and transportable devices has expanded testing capabilities beyond hospitals to homes, emergency care, and convenience clinics, meeting the growing demand for accessible diagnostics.

Market Drivers

The increasing prevalence of chronic and infectious diseases is a primary driver of the POC diagnostics market. In emerging nations like China and India, the rising incidence of cardiovascular diseases and diabetes has heightened demand. For instance, the International Diabetes Federation reported in 2021 that 537 million adults aged 20-79 globally were living with diabetes, with significant numbers in these countries. Similarly, infectious diseases such as HIV and tuberculosis (TB) are fueling market growth. UNAIDS estimated 20.6 million people were living with HIV in 2019, including 2.1 million in India, driving demand for POC diagnostics to accelerate treatment. The World Health Organization noted India's high TB burden, with 2.64 million cases in 2020, further emphasizing the need for rapid diagnostics in resource-limited settings. Additionally, respiratory syncytial virus (RSV) affects four to five million children annually worldwide, contributing to the demand for POC testing to manage such disorders effectively.

Geographical Outlook

North America is poised for significant growth in the POC diagnostics market during the forecast period. The surge in COVID-19 cases has been a key factor, increasing the need for rapid testing solutions. The region benefits from robust product innovation, a rising incidence of infectious and chronic diseases, and supportive governmental initiatives promoting early detection and regular health check-ups. The United States and Canada are pivotal markets, driven by increased healthcare expenditure, a growing number of hospitals and diagnostic laboratories, and strategic collaborations among industry players. These factors collectively enhance the adoption of POC devices, positioning North America as a leader in market expansion.

The POC diagnostics market is expanding rapidly due to the rising prevalence of chronic and infectious diseases, technological advancements in portable devices, and supportive healthcare policies, particularly in North America. The market's growth is further propelled by the need for rapid, accessible diagnostics in diverse settings, addressing critical healthcare challenges in both developed and emerging regions.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries

Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Point of Care Diagnostics Market Segmentation

By Testing

• Cardio-Metabolic Monitoring Kits
• Infectious Disease Testing Kits
• Glucose Monitoring Kits
• Coagulation Monitoring Kits
• Tumor/Cancer Markers
• Pregnancy & Fertility Testing
• Urinalysis Testing Kit
• Hematology Testing
• Others

By Platform

• Lateral Flow Assay
• Dipstick
• MicroFluids
• Molecular Diagnostics
• Others

By Mode

• Prescription
• Over-the-counter (OTC)

By End-User

• Hospitals
• Diagnostics Centers
• Others

By Geography

• North America
• USA
• Canada
• Others
• South America
• Brazil
• Others
• Europe
• Germany
• UK
• France
• Spain
• Others
• Middle East and Africa
• Israel
• Others
• Asia Pacific
• China
• Japan
• South Korea
• India
• Thailand
• Indonesia
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. POINT OF CARE DIAGNOSTICS MARKET BY TESTING

• 5.1. Introduction
• 5.2. Cardio-Metabolic Monitoring Kits
• 5.3. Infecious Disease Testing Kits
• 5.4. Glucose Monitoring Kits
• 5.5. Coagulation Monitoring Kits
• 5.6. Tumor/Cancer Marker
• 5.7. Pregnancy & Fertility Testing
• 5.8. Urinalysis Testing Kit
• 5.9. Hematology Testing
• 5.10. Others

6. POINT OF CARE DIAGNOSTICS MARKET BY PLATFORM

• 6.1. Introduction
• 6.2. Lateral Flow Assay
• 6.3. Dipsticks
• 6.4. Microfluids
• 6.5. Molecular Diagnostics
• 6.6. Others

7. POINT OF CARE DIAGNOSTICS MARKET BY MODE

• 7.1. Introduction
• 7.2. Prescription
• 7.3. Over-The-Counter (OTC)

8. POINT OF CARE DIAGNOSTICS MARKET BY END-USER

• 8.1. Introduction
• 8.2. Hospitals
• 8.3. Diagnostics Centers
• 8.4. Others

9. POINT OF CARE DIAGNOSTICS MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. USA
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. Germany
  • 9.4.2. France
  • 9.4.3. United Kingdom
  • 9.4.4. Spain
  • 9.4.5. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. India
  • 9.6.3. Japan
  • 9.6.4. South Korea
  • 9.6.5. Indonesia
  • 9.6.6. Thailand
  • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Abbott Laboratories
• 11.2. Becton, Dickinson and Company
• 11.3. Biosynex
• 11.4. Danaher Corporation
• 11.5. EKF Diagnostics
• 11.6. Nova Biomedical
• 11.7. Quidel Corporation
• 11.8. Siemens AG
• 11.9. Trinity Biotech
• 11.10. WerfenLife S.A

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key benefits for the stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations